| Code | Display |
| mms |
ICD-11 for Mortality and Morbidity Statistics |
| 1630407678 |
Neoplasms |
| 1766440644 |
Diseases of the blood or blood-forming organs |
| 1954798891 |
Diseases of the immune system |
| 1435254666 |
Certain infectious or parasitic diseases |
| 21500692 |
Endocrine, nutritional or metabolic diseases |
| 2A00-2A0Z |
Neoplasms of central nervous system or related structures |
| 2B50-2E2Z |
Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues |
| 2A20-2B3Z |
Neoplasms of haematopoietic or lymphoid tissues |
| 2E60-2E6Z |
In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues |
| 2E80-2F3Z |
Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues |
| 2E62 |
Carcinoma in situ of middle ear or respiratory system |
| 2E61 |
Carcinoma in situ of other or unspecified digestive organs |
| 2E60 |
Carcinoma in situ of oral cavity, oesophagus or stomach |
| 2E90-2F3Z |
Benign neoplasms except of mesenchymal origin |
| 2E80-2E8Z |
Benign mesenchymal neoplasms |
| 1B70-1B7Z |
Pyogenic bacterial infections of the skin or subcutaneous tissues |
| 1B10-1B2Z |
Mycobacterial diseases |
| 1A60-1A9Z |
Predominantly sexually transmitted infections |
| 1A00-1A40.Z |
Gastroenteritis or colitis of infectious origin |
| 2E64 |
Carcinoma in situ of skin |
| 2E63 |
Melanoma in situ neoplasms |
| 1B40-1B5Z |
Certain staphylococcal or streptococcal diseases |
| 5B50-5C3Z |
Nutritional disorders |
| 5C50-5D2Z |
Metabolic disorders |
| 5D40-5D46 |
Postprocedural endocrine or metabolic disorders |
| 5A00-5B3Z |
Endocrine diseases |
| 2E81 |
Benign vascular neoplasms |
| 2E84 |
Benign fibrogenic or myofibrogenic tumour |
| 2E80 |
Benign lipomatous neoplasm |
| 2E92 |
Benign neoplasm of digestive organs |
| 2E90 |
Benign neoplasm of lip, oral cavity or pharynx |
| 2F00-2F01 |
Benign neoplasm of middle ear, respiratory or intrathoracic organs |
| 2E91 |
Benign neoplasm of major salivary glands |
| 1B10-1B1Z |
Tuberculosis |
| 2F10 |
Fibrous benign mesothelioma of omentum |
| 2E83 |
Benign osteogenic tumours |
| 1B74 |
Superficial bacterial folliculitis |
| 2D50-2E2Z |
Malignant neoplasm metastases |
| 1B70 |
Bacterial cellulitis, erysipelas or lymphangitis |
| 1B71 |
Necrotising fasciitis |
| 1A20-1A2Z |
Viral intestinal infections |
| 1A30-1A3Z |
Protozoal intestinal infections |
| 1B72 |
Impetigo |
| 1B73 |
Ecthyma |
| 2E82 |
Benign chondrogenic tumours |
| 2D40-2D4Z |
Malignant neoplasms of ill-defined or unspecified primary sites |
| 2B50-2D3Z |
Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues |
| 1B21 |
Infections due to non-tuberculous mycobacteria |
| 1B20 |
Leprosy |
| 2E63.0 |
Melanoma in situ of skin |
| 1B2Y |
Other specified mycobacterial diseases |
| 1B54 |
Staphylococcal spinal meningitis |
| 1B50 |
Otitis media in scarlet fever |
| 1B53 |
Meningitis due to Streptococcus agalactiae |
| 1B40-1B42 |
Acute rheumatic fever |
| 1B51 |
acute streptococcal ulcerated sore throat |
| 1A00-1A0Z |
Bacterial intestinal infections |
| 1A10-1A1Z |
Bacterial foodborne intoxications |
| 2E63.1 |
Melanoma in situ of conjunctiva |
| 2E63.Y |
Melanoma in situ neoplasms, other specified site |
| 1B2Z |
Mycobacterial diseases, unspecified |
| 2E63.Z |
precancerous melanosis of unspecified site |
| 1A40 |
Gastroenteritis or colitis without specification of infectious agent |
| 4A60-4A6Z |
Autoinflammatory disorders |
| 4A20 |
Acquired immunodeficiencies |
| 4A80-4A8Z |
Allergic or hypersensitivity conditions |
| 4A40-4A4Z |
Nonorgan specific systemic autoimmune disorders |
| 4A00-4A0Z |
Primary immunodeficiencies |
| 2E61.3 |
gallbladder carcinoma in situ |
| 2E60.2 |
Carcinoma in situ of intraepithelium of stomach |
| 2E60.1 |
Glandular intraepithelial neoplasia of oesophagus, high grade |
| 2E61.0 |
Carcinoma in situ of rectosigmoid junction |
| 2E61.2 |
AIN - [anal intraepithelial neoplasia] high grade |
| 2E61.1 |
Intraepithelial neoplasia (dysplasia) of rectum, high grade |
| 2E61.Y |
Carcinoma in situ of tail of pancreas |
| 2E62.2 |
pulmonary carcinoma in situ |
| 2E62.Z |
Carcinoma in situ of middle ear or respiratory system |
| 2E62.Y |
Carcinoma in situ of vestibule of nose |
| 2E62.0 |
Carcinoma in situ of thyroid cartilage |
| 2E60.0 |
Carcinoma in situ upper labial sulcus |
| 2E62.1 |
Intraepithelial neoplasia (dysplasia) of trachea, high grade |
| 2A00 |
Primary neoplasms of brain |
| 2A02 |
Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system |
| 2A0Z |
Nonpolyposis Turcot syndrome |
| 2A01 |
primary neoplasm of spinal meninges |
| 5B50-5B7Z |
Undernutrition |
| 5C3Y |
Skin disorder attributable to food fads or unhealthy diet |
| 5C3Z |
Nutritional liver disease, not elsewhere classified |
| 2E64.0 |
Intraepidermal squamous cell carcinoma |
| 5B80-5C1Z |
Overweight, obesity or specific nutrient excesses |
| 2E64.Z |
skin carcinoma in situ |
| 2E64.1 |
Extramammary Paget disease of anogenital skin |
| 2E64.Y |
Apocrine adenocarcinoma in situ of unspecified site |
| 2E64.2 |
High grade squamous intraepithelial lesion of anal margin or perianal skin |
| 5D40 |
Postprocedural hypothyroidism |
| 5D41 |
Postpancreatectomy hyperglycaemia |
| 5A50-5A5Z |
Disorders of the parathyroids or parathyroid hormone system |
| 5D42 |
Parathyroprival tetany |
| 5D43 |
Postirradiation hypopituitarism |
| 5D44 |
iatrogenic ovarian failure |
| 5A40-5A4Z |
Other disorders of glucose regulation or pancreatic internal secretion |
| 5A10-5A2Y |
Diabetes mellitus |
| 5A60-5A6Z |
Disorders of the pituitary hormone system |
| 5A00-5A0Z |
Disorders of the thyroid gland or thyroid hormones system |
| 2E84.0 |
Benign fibrogenic or myofibrogenic tumour of skin |
| 2E84.Z |
Myxoma of unspecified site |
| 2E84.Y |
Benign fibrogenic or myofibrogenic tumour of other specified sites |
| 2E80.Y |
Other specified benign lipomatous neoplasm |
| 2E80.1 |
Lipoblastoma |
| 2E80.0 |
Lipoma |
| 2E80.Z |
Benign adipocytic tumour |
| 2E92.4 |
Benign neoplasm of the large intestine |
| 2E92.2 |
Other benign neoplasm of duodenum |
| 2E92.1 |
benign tumour of pylorus |
| 2F00 |
Benign neoplasm of middle ear or respiratory system |
| 2E90.3 |
Benign tumour of internal cheek |
| 2E92.0 |
benign tumour of upper third of oesophagus |
| 2E92.3 |
benign tumour of ileal diverticulum |
| 2E83.2 |
benign neoplasm of vertebra |
| 2E90.2 |
benign tumour of floor of mouth |
| 2E83.3 |
benign neoplasm of clavicle |
| 2E90.1 |
Granular cell myoblastoma of tongue |
| 2E90.4 |
benign tumour of tonsil |
| 1B71.0 |
Necrotising fasciitis type 2 |
| 2E90.0 |
Benign tumour of upper labial mucosa |
| 2F01 |
Benign neoplasm of visceral pleura |
| 2E83.0 |
Upper jaw dentinoma |
| 2F20-2F2Z |
Benign cutaneous neoplasms |
| 2E83.1 |
Periradicular cemental dysplasia of lower jaw |
| 2E83.4 |
Benign neoplasm of sacrum |
| 2D70-2D7Z |
Malignant neoplasm metastasis in thoracic or respiratory organs |
| 1B74.Z |
Superficial folliculitis |
| 1B74.0 |
Follicular impetigo of Bockhart |
| 1B71.1 |
Progressive bacterial synergistic gangrene |
| 1B71.2 |
Neonatal streptococcal necrotising fasciitis |
| 2D52 |
Malignant neoplasm metastasis in epidural space |
| 2D60-2D6Z |
Malignant neoplasm metastasis in lymph nodes |
| 2D50 |
Malignant neoplasm metastasis in choroid plexus |
| 1B71.Z |
necrotizing fasciitis |
| 2D51 |
spinal arachnoid metastasis |
| 1B71.Y |
Necrotising fasciitis, trunk |
| 1A31 |
Colitis due to Giardia lamblia |
| 1A33 |
Cystoisosporiasis |
| 1B74.Y |
Hot tub folliculitis |
| 1A34 |
sarcosporidiasis |
| 2E82.0 |
Benign chondrogenic tumours of bone or articular cartilage of limbs |
| 1A32 |
Cryptosporidial colitis |
| 1A30 |
Balantidium coli anaemia |
| 2E82.Z |
giant cell chondromatous tumour of unspecified site |
| 2C30-2C3Z |
Malignant neoplasms of skin |
| 2B70-2C1Z |
Malignant neoplasms of digestive organs |
| 2E82.1 |
Benign chondrogenic tumours of bone or articular cartilage of other specified sites |
| 1B73.Z |
Ecthyma |
| 1B73.2 |
Ecthyma gangrenosum |
| 1B73.1 |
Staphylococcal ecthyma |
| 1B73.0 |
Streptococcal ecthyma |
| 2B60-2B6Y |
Malignant neoplasms of lip, oral cavity or pharynx |
| 2C20-2C2Z |
Malignant neoplasms of middle ear, respiratory or intrathoracic organs |
| 1B73.Y |
Other specified ecthyma |
| 2B50-2B5Z |
Malignant mesenchymal neoplasms |
| 1B20.2 |
Leprosy reactions |
| 1B20.3 |
Mycobacterium leprae dacryoadenitis |
| 1B20.Z |
leprosy unspecified |
| 1B20.1 |
Hansen disease, diffuse lepromatous |
| 2E63.00 |
Hutchinson melanotic freckle |
| 2E63.0Z |
Radial growth phase malignant melanoma |
| 1B5Y |
Staphylococcal pericarditis |
| 1B20.0 |
BT - [borderline tuberculoid] leprosy |
| 1B40 |
Acute rheumatic fever without mention of heart involvement |
| 1B41 |
Acute rheumatic fever with heart involvement |
| 1B42 |
ST Vitus dance |
| 1B5Z |
sepsis due to group B Strep without mention of septic shock |
| 4A61 |
SAPHO - [synovitis, acne, pustulosis, hyperostosis, osteitis] syndrome |
| 4A6Z |
Autoinflammatory disorders, unspecified |
| 4A6Y |
Juvenile chronic recurrent multifocal osteomyelitis |
| 4A60 |
Monogenic autoinflammatory syndromes |
| 4A20.1 |
Acquired immunodeficiency due to protein loss |
| 4A62 |
Neurological complications of Behçet disease |
| 4A20.Z |
Acquired immunodeficiencies |
| 4A20.Y |
Other specified acquired immunodeficiencies |
| 4A84 |
Anaphylaxis |
| 4A80 |
Allergic or hypersensitivity disorders involving the respiratory tract |
| 4A20.0 |
Adult-onset immunodeficiency |
| 4A83 |
Allergic or hypersensitivity disorders involving the gastrointestinal tract |
| 4A82 |
Arthus phenomenon |
| 4A81 |
Ocular allergy |
| 4A41 |
Idiopathic inflammatory myopathy |
| 4A43 |
Overlap or undifferentiated nonorgan specific systemic autoimmune disease |
| 4A42 |
Systemic sclerosis |
| 4A44 |
Vasculitis |
| 4A40 |
Lupus erythematosus |
| 2E61.Z |
Carcinoma in situ of other or unspecified digestive organs |
| 4A0Y |
Lymphocyte function antigen-1 [LFA-1] defect |
| 4A0Z |
Primary immunodeficiencies, unspecified |
| 4A01 |
Primary immunodeficiencies due to disorders of adaptive immunity |
| 4A00 |
Primary immunodeficiencies due to disorders of innate immunity |
| 1A90 |
Chancroidal lymphadenitis |
| 1A91 |
Osteomyelitis due to Klebsiella granuloma inguinale |
| 1A70-1A7Z |
Gonococcal infection |
| 1A60-1A6Z |
Syphilis |
| 1A80-1A8Z |
Sexually transmissible infections due to chlamydia |
| 2A00.3 |
Central neurocytoma of brain |
| 2A00.4 |
astroblastoma of unspecified site |
| 2A00.2 |
Tumours of neuroepithelial tissue of brain |
| 2A00.1 |
Embryonal tumours of brain |
| 2A00.0 |
Gliomas of brain |
| 2A02.4 |
Benign neoplasm of cauda equina |
| 2A02.0 |
Gliomas of spinal cord, cranial or paraspinal nerves |
| 2A02.2 |
primary malignant neoplasm of cauda equina |
| 2A01.0 |
Meningiomas |
| 2A02.1 |
Tumours of cranial or paraspinal nerves |
| 2A02.3 |
acoustic neurinoma |
| 2A01.2 |
Neoplasm of uncertain or unknown behaviour of spinal meninges |
| 2A01.1 |
Mesenchymal tumours of meninges |
| 2A20-2A2Z |
Myeloproliferative neoplasms |
| 2A40-2A4Z |
Myelodysplastic and myeloproliferative neoplasms |
| 2A60 |
Acute myeloid leukaemias and related precursor neoplasms |
| 2A30-2A3Z |
Myelodysplastic syndromes |
| 2A50-2A5Z |
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 |
| 2E91.0 |
benign tumour of parotid gland |
| 2E91.Z |
Warthin tumour of unspecified site |
| 1B12 |
Tuberculosis of other systems and organs |
| 1B13 |
Miliary tuberculosis |
| 1B11 |
Tuberculosis of the nervous system |
| 2E91.1 |
Benign neoplasm of submaxillary gland |
| 1B14 |
Carrier of Mycobacterium tuberculosis |
| 1B10 |
Tuberculosis of the respiratory system |
| 1B70.0 |
Erysipelas |
| 1B70.2 |
Staphylococcal cellulitis of skin |
| 1B70.3 |
Ascending bacterial lymphangitis due to Staphylococcus aureus |
| 1B70.Y |
Bacterial cellulitis or lymphangitis due to other specified bacterium |
| 1B70.1 |
Streptococcal cellulitis of the vulva and vagina |
| 1A22 |
rotaviral enteritis |
| 1A20 |
Adenoviral enteritis |
| 1A24 |
Gastroenteritis due to Cytomegalovirus |
| 1A21 |
infections due to Astrovirus |
| 2D44 |
metastatic cancer, unknown origin, so stated |
| 2D41 |
Metastatic carcinoma [primary carcinoma spreading elsewhere] |
| 1A23 |
Noroviral enteritis |
| 2D43 |
Malignant neoplasms of independent, multiple primary sites |
| 2D40 |
Villous adenocarcinoma in adenoma of unspecified site |
| 2D42 |
calf cancer |
| 2E64.00 |
Bowen type intraepidermal squamous cell carcinoma |
| 2E64.0Y |
Other specified intraepidermal squamous cell carcinoma |
| 2E64.01 |
Intraepidermal squamous cell carcinoma arising from actinic keratosis |
| 2E64.0Z |
IEC - [intraepidermal carcinoma] |
| 5B90-5B9Z |
Certain specified nutrient excesses |
| 5B80-5B81.Z |
Overweight or obesity |
| 5C1Z |
Overweight, obesity or specific nutrient excesses, unspecified |
| 5C1Y |
late effect of hyperalimentation |
| 5D40.Y |
Other specified postprocedural hypothyroidism |
| 5D40.0 |
Postirridation hypothyroidism |
| 5D40.Z |
hypothyroidism due to absence of thyroid |
| 5D45 |
Postprocedural testicular hypofunction |
| 5D46 |
adrenalectomy status |
| 5A60 |
Hyperfunction of pituitary gland |
| 5A61 |
hypothalamic lesion |
| 5A6Z |
Disorders of the pituitary hormone system, unspecified |
| 5A11 |
insulin resistant diabetes |
| 5A10 |
SPIDDM - [Slowly progressive insulin-dependent diabetes mellitus] |
| 5A13 |
Other specified Diabetes mellitus, not Type 1 and not Type 2 |
| 5A14 |
Diabetes without mention of type of diabetes mellitus |
| 5A00 |
Hypothyroidism |
| 5A02 |
Thyrotoxicosis |
| 5A12 |
malnutrition-related diabetes mellitus without complications |
| 5A04 |
C-cell hyperplasia of thyroid |
| 5A03 |
Thyroiditis |
| 5A01 |
Nontoxic goitre |
| 2E85 |
Benign fibrohistiocytic tumour |
| 2E80.00 |
Superficial subcutaneous lipoma |
| 2E80.0Y |
Lipoma, other specified site |
| 2E80.01 |
Benign lipoma of spermatic cord |
| 2E80.02 |
Deep internal benign lipoma of retroperitoneum |
| 2E80.0Z |
Spindle cell lipoma of unspecified site |
| 2E92.4Z |
benign tumor of large intestine |
| 2E92.40 |
HMPS - [hereditary mixed polyposis syndrome] |
| 2E92.4Y |
Tubular adenoma of sigmoid |
| 2F00.Z |
Benign neoplasm of middle ear or respiratory system |
| 2F00.0 |
Middle ear neuroendocrine tumour |
| 2F00.1 |
Recurrent respiratory papillomatosis |
| 2E92.5 |
Benign anorectal neoplasm |
| 2E92.6 |
Other benign neoplasms of gallbladder, extrahepatic bile duct or ampulla of Vater |
| 2F00.2 |
Laryngeal neuroendocrine tumour |
| 2E92.7 |
biliary ductal cystadenoma |
| 2F00.Y |
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia |
| 2E90.5 |
Benign tumour of mesopharynx |
| 2E83.5 |
Benign neoplasm of patella |
| 2E90.6 |
Benign neoplasm of the pharyngeal tonsil |
| 2F21 |
Benign keratinocytic acanthomas |
| 2F20 |
Benign cutaneous melanocytic neoplasms |
| 2F23 |
Benign dermal fibrous or fibrohistiocytic neoplasms |
| 2F24 |
Cellular neurothekeoma |
| 2E83.Y |
Benign osteogenic tumour of other specified site |
| 2D71 |
mediastinum metastasis |
| 2D72 |
pleural metastasis |
| 2D7Y |
tracheal cartilage metastasis |
| 2F22 |
Tubular papillary adenoma |
| 2D70 |
Metastatic carcinoma in lung |
| 2D73 |
Malignant neoplasm metastasis in false vocal cord |
| 2E83.Z |
Osteoma of unspecified site |
| 2D90-2D91 |
Malignant neoplasm metastasis in retroperitoneum or peritoneum |
| 2D80-2D8Z |
Malignant neoplasm metastasis in digestive system |
| 2E00-2E0Y |
Malignant neoplasm metastasis in other specified sites |
| 1A33.0 |
Infection due to Isopora belli |
| 1A33.1 |
coccidial colitis |
| 1B75 |
Deep bacterial folliculitis or pyogenic abscess of the skin |
| 1A35 |
Blastocystosis |
| 1A33.Y |
Other specified cystoisosporiasis |
| 1A36 |
Amoebiasis |
| 1A33.Z |
Isosporiasis |
| 1A3Z |
Protozoal intestinal infections, unspecified |
| 1A3Y |
embadomonas dysentery |
| 2E86 |
Benign smooth muscle or skeletal muscle tumour |
| 1B7Y |
Skin infection classified elsewhere due to hospital-acquired MRSA |
| 1B20.20 |
Leprosy upgrading reaction |
| 1B20.21 |
Lucio phenomenon |
| 2E65 |
Carcinoma in situ of breast |
| 1B40.0 |
acute articular rheumatism |
| 1B40.Z |
subacute rheumatic fever |
| 1B40.Y |
rheumatic pneumonitis |
| 2E81.Y |
Other specified benign vascular neoplasms |
| 2E81.2 |
Benign vascular neoplasms of infancy or childhood |
| 2E81.0 |
Neoplastic haemangioma |
| 2E81.Z |
Benign vascular neoplasms |
| 2E81.1 |
Benign lymphatic neoplasms |
| 4A60.2 |
Tumour necrosis factor receptor 1 associated periodic syndrome with amyloidosis |
| 4A60.1 |
Muckle Wells Syndrome with neurosensorial hearing loss |
| 4A60.0 |
Familial Mediterranean fever with amyloidosis |
| 4A60.Z |
Monogenic autoinflammatory syndromes |
| 4A60.Y |
NLRP12-associated hereditary periodic fever syndrome |
| 4A84.0 |
Anaphylactic shock due to allergic food reaction |
| 4A84.3 |
Anaphylaxis provoked by physical factors |
| 4A84.2 |
Insect venom allergen-induced anaphylaxis |
| 4A84.4 |
Inhaled allergen-induced anaphylaxis |
| 4A84.1 |
medicament-induced anaphylaxis |
| 4B00-4B0Z |
Immune system disorders involving white cell lineages |
| 4A80.Y |
Other specified allergic or hypersensitivity disorders involving the respiratory tract |
| 4A80.1 |
Food-induced wheezing |
| 4A80.Z |
Allergic or hypersensitivity disorders involving the respiratory tract |
| 4A80.0 |
medicament-induced bronchospasm |
| 4A83.1 |
Food-induced eosinophilic oesophagitis |
| 4A83.Y |
Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract |
| 4A83.Z |
Allergic or hypersensitivity disorders involving the gastrointestinal tract |
| 4A83.0 |
Food-induced eosinophilic gastroenteritis |
| 4A85 |
Complex allergic or hypersensitivity conditions |
| 4A8Y |
Allergic or hypersensitivity conditions of other specified type |
| 4A41.0 |
Dermatomyositis |
| 4A41.Y |
Focal myositis |
| 4A41.2 |
Inclusion body myopathy |
| 4A41.1 |
Polymyositis |
| 4A41.Z |
Idiopathic inflammatory myopathy |
| 4A43.2 |
Sjögren syndrome |
| 4A43.3 |
Paediatric-onset MCTD - [mixed connective tissue disease] |
| 4A44.2 |
Giant cell arteritis without polymyalgia rheumatica |
| 4A43.1 |
Mikulicz disease |
| 4A43.0 |
Cholangitis of IgG4-related sclerosing disease |
| 4A43.4 |
Diffuse fasciitis |
| 4A40.1 |
drug-induced systemic lupus erythematosus |
| 4A44.0 |
Rhizomelic pseudopolyarthritis |
| 4A44.3 |
Single organ vasculitis |
| 4A40.Y |
Lupus erythematosus of oral mucosa |
| 4A40.0 |
Systemic lupus erythematosus |
| 4A44.4 |
Periarteritis nodosa with necrosis |
| 4A44.1 |
young female aortic arch arteritis syndrome |
| 4A40.Z |
LE - [lupus erythematosus] |
| 4A01.1 |
Combined immunodeficiencies |
| 4A01.2 |
Diseases of immune dysregulation |
| 4A01.0 |
Immunodeficiencies with predominantly antibody defects |
| 4A01.Z |
Primary immunodeficiencies due to disorders of adaptive immunity |
| 4A01.3 |
Other well-defined immunodeficiency syndromes due to defects in adaptive immunity |
| 4A00.1 |
Defects in the complement system |
| 4A00.3 |
Immunodeficiency with NK-cell - [natural-killer cell] deficiency |
| 4A00.Y |
Warts - hypogammaglobulinaemia - infections - myelokathexis |
| 4A00.2 |
Pyogenic bacterial infections due to MyD88 deficiency |
| 4A00.0 |
Functional neutrophil defects |
| 1A93 |
Sexually transmissible infestations |
| 1A92 |
Trichomonal cervicitis |
| 1A60 |
Congenital syphilis |
| 1A61 |
Early syphilis |
| 1A63 |
Positive Wassermann test |
| 1A6Z |
Female syphilitic pelvic inflammatory disease |
| 1A62 |
Late syphilis |
| 1B72.0 |
Blistering distal dactylitis |
| 1B72.Y |
Other specified impetigo |
| 1B72.1 |
Non-bullous impetigo |
| 1B21.1 |
Non-tuberculous mycobacterial lymphadenitis |
| 1B21.0 |
Pulmonary infection due to Mycobacterium malmoense |
| 1B21.4 |
Non-tuberculous mycobacterial colitis |
| 2A00.20 |
Pineocytoma |
| 2A00.21 |
Lhermitte-Duclos disease |
| 2A00.22 |
choroid plexus carcinoma (grade 3 lesion) |
| 2A00.2Y |
Other specified tumours of neuroepithelial tissue of brain |
| 2A00.0Z |
glioma NOS |
| 2A00.2Z |
Tumours of neuroepithelial tissue of brain |
| 2A00.5 |
benign brain tumour NOS |
| 2A00.1Y |
Yolk sac tumour of the central nervous system |
| 1B21.3 |
DMAC - [disseminated mycobacterium avium-intracellulare complex infection] |
| 2A02.00 |
Glioblastoma of spinal cord, cranial or paraspinal nerves |
| 2A02.0Z |
Gliomas of spinal cord, cranial or paraspinal nerves |
| 2A02.0Y |
Malignant astrocytomas of spinal cord, cranial or paraspinal nerves |
| 2A00.00 |
Spongioblastoma multiforme of unspecified site |
| 2A00.10 |
Neuroepithelioma |
| 2A00.1Z |
Embryonal tumours of brain |
| 2A00.0Y |
Subependymal glioma, unspecified site |
| 2A02.10 |
neurofibrosarcoma |
| 2A00.11 |
Teratoid medulloepithelioma of unspecified site |
| 2A20 |
Non mast cell myeloproliferative neoplasms |
| 2A60.4 |
Myeloid proliferation associated with Down syndrome |
| 2A60.1 |
Acute myeloid leukaemia with multilineage dysplasia in complete remission |
| 2A60.2 |
Therapy-related myeloid neoplasms |
| 2A40 |
CMML-2 - [chronic myelomonocytic leukaemia Type 2] |
| 2A60.0 |
Acute myeloid leukemia with t(8;21)(q22;q22) translocation |
| 2A41 |
Atypical chronic myeloid leukaemia, BCR-ABL1-negative in complete remission |
| 1B12.2 |
Tuberculosis of inner ear |
| 1B12.0 |
tuberculous pericarditis |
| 2A01.0Z |
benign meningioma (deprecated) |
| 2A2Z |
myeloproliferative disorder |
| 1B1Y |
Disorders of kidney or ureter in tuberculosis |
| 1B11.1 |
Tuberculous meningoencephalitis |
| 2A60.3 |
Acute myeloid leukaemia, not elsewhere classified by criteria of other types |
| 1B11.2 |
Tuberculoma of spinal meninges |
| 2A43 |
RARS-T [Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis](provisional) |
| 2A42 |
Juvenile myelomonocytic leukaemia |
| 2A44 |
Myeloproliferative and myelodysplastic disease, unclassifiable in complete remission |
| 2A51 |
Myeloid neoplasms with PDGFRB rearrangement |
| 2A02.Z |
Epidural cancer NOS |
| 1B13.2 |
Acute miliary tuberculosis, unspecified site |
| 1B13.1 |
tuberculous polyserositis |
| 1B13.Y |
Chronic multiple tuberculosis |
| 1B13.Z |
disseminated tuberculosis |
| 1B11.3 |
tuberculoma of brain |
| 1B11.0 |
spinal meningeal TBC - [tuberculosis] |
| 1B11.Y |
tuberculous cerebrum arteritis |
| 2A01.0Y |
Syncytial meningioma of unspecified site |
| 2A2Y |
chronic myeloproliferative disease NOS |
| 1A40.0 |
jejunal inflammation |
| 2E92.8 |
benign tumour of tail of pancreas |
| 1A40.Z |
intestinal infections without specification of infectious agent |
| 1B13.0 |
Acute miliary lung TBC - [tuberculosis] |
| 2F30 |
Benign neoplasm of breast |
| 1B10.0 |
Tuberculous sinusitis of any sinus, with bacteriological and histological confirmation |
| 1B7Z |
suppurative dermatitis |
| 1B12.5 |
Tuberculosis of breast |
| 1B10.Z |
Tuberculous pansinusitis |
| 2D61 |
Malignant neoplasm metastasis in lymph nodes of multiple regions by adenocarcinoma |
| 2D6Z |
lymphatic vessel metastasis |
| 1B70.Z |
Cellulitis not otherwise specified |
| 2E81.2Y |
Diffuse neonatal haemangiomatosis |
| 2E90.7 |
Benign tumour of pharyngoesophageal junction |
| 1A2Z |
Viral gastroenteropathy NOS |
| 2E81.21 |
Multiple strawberry haemangiomata |
| 1B12.6 |
TB - [tuberculosis] axillary gland |
| 2B63 |
Malignant neoplasms of gum |
| 2B64 |
Malignant neoplasms of floor of mouth |
| 2B61 |
Malignant neoplasms of base of tongue |
| 2E66 |
Carcinoma in situ of cervix uteri |
| 2D60 |
Malignant neoplasm metastasis in lymph node of a single region |
| 5B80 |
Overweight or localised adiposity |
| 5B81 |
Obesity |
| 5B90 |
Vitamin excesses |
| 1A2Y |
Enteritis due to coxsackievirus |
| 1B12.8 |
Tuberculous gumma |
| 5A05 |
Refetoff syndrome |
| 2F20.Y |
Unclassifiable benign cutaneous melanocytic proliferation |
| 5B91 |
Mineral excesses |
| 5B9Z |
Nutrient excesses, unspecified |
| 2D4Z |
Cancer in polyp |
| 2B60 |
Malignant neoplasms of lip |
| 2B62 |
Malignant neoplasms of other or unspecified parts of tongue |
| 5A00.0 |
Congenital hypothyroidism |
| 5A00.Z |
Subclinical hypothyroidism |
| 5A00.1 |
Iodine-deficiency-related thyroid disorders or allied conditions |
| 5A20-5A2Y |
Acute complications of diabetes mellitus |
| 4A43.Y |
Other specified non-organ specific systemic autoimmune disorders, not elsewhere classified, associated with anti-RNP antibodies |
| 2E87 |
GIST - [gastrointestinal stromal tumour] of appendix |
| 5D40.0Z |
Postirridation hypothyroidism |
| 2F20.2 |
Congenital melanocytic naevus |
| 2F20.3 |
Generalised eruptive melanocytic naevi |
| 2F20.1 |
Melanocytic naevus with mild to moderate dysplasia |
| 2F20.Z |
Naevus pigmentosus |
| 5B9Y |
Other specified nutrient excesses |
| 2E92.Y |
Benign neoplasm of other specified digestive organs |
| 4A42.Z |
Myopathy in scleroderma |
| 2F21.0 |
Traumatized seborrhoeic keratosis |
| 2F25 |
de Morgan's spots |
| 2F23.0 |
Subepidermal nodular fibrosis |
| 2F23.Y |
Fibrous papule of nose |
| 2E90.8 |
benign tumour of Waldeyer ring |
| 2E88 |
Stromal nodule |
| 2E92.Z |
benign tumour of intestine NOS |
| 4A42.2 |
CRST - [calcinosis, Raynaud phenomenon, sclerodactyly and telangiectasia] syndrome |
| 2D80 |
Secondary malignant neoplasm of liver or intrahepatic bile duct |
| 2D84 |
duodenal metastasis |
| 2D82 |
metastasis to ductus choledochus |
| 2F26 |
Pyogenic granuloma |
| 1A70 |
Gonococcal genitourinary infection |
| 2D90 |
secondary malignant neoplasm of retroperitoneum |
| 1B75.0 |
Boil |
| 1B75.2 |
Furunculosis |
| 2D91 |
malignant ascites NOS |
| 4A01.30 |
Immunodeficiency due to absence of thymus |
| 4A01.32 |
Schimke syndrome |
| 2E86.2 |
Glycogenic rhabdomyoma |
| 1A72 |
Gonococcal infection of other sites |
| 1A36.Z |
amoebiasis, unspecified |
| 1A7Z |
Infection due to Neisseria gonorrhoeae |
| 2D7Z |
thorax metastasis |
| 4A01.33 |
VODI - [Veno-occlusive disease immunodeficiency] syndrome |
| 4A01.31 |
ATLD - [Ataxia-telangiectasia-like disorder] |
| 4A01.34 |
Hyperimmunoglobulin E syndrome due to TYK2 deficiency |
| 2E86.Z |
myoma of unspecified site |
| 1A36.0 |
Intestinal infections due to Entamoeba |
| 2D86 |
anal canal metastasis |
| 1B75.3 |
abscess NOS |
| 1B75.1 |
Carbuncle |
| 3A00-3A9Z |
Anaemias or other erythrocyte disorders |
| 2A30 |
refractory anaemia without sideroblasts |
| 3B10-3B6Z |
Coagulation defects, purpura or other haemorrhagic or related conditions |
| 3B80-3B8Z |
Diseases of spleen |
| 2A01.00 |
Familial multiple meningioma |
| 1A10 |
staphylococcus poisoning |
| 1A00 |
Cholera due to Vibrio cholerae O139 |
| 1B21.2 |
Cutaneous non-tuberculous mycobacterial infection |
| 1A71 |
Gonococcal ovarian abscess |
| 1A12 |
pigbel |
| 2B50 |
Chondrosarcoma, primary site |
| 2A32 |
Refractory thrombocytopenia |
| 2A31 |
Refractory neutropaenia |
| 2B52 |
Ewing sarcoma, primary site |
| 1A70.0 |
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess |
| 2A21 |
Mastocytosis |
| 1A70.1 |
Gonococcal abscess of penis |
| 1A02 |
Sepsis due to shigella with septic shock |
| 1A81 |
Non-ulcerative sexually transmitted chlamydial infection |
| 1A60.1 |
Early congenital syphilis, latent |
| 1A8Y |
Other specified sexually transmissible infections due to chlamydia |
| 1A01 |
Infections due to Vibrio vulnificus |
| 1A80 |
chlamydial lymphogranuloma venereum |
| 1B10.1 |
tuberculous pleural effusion, not confirmed |
| 1A11 |
Botulism |
| 1A72.1 |
Infection of the rectum due to Neisseria gonorrhoeae |
| 1A72.2 |
Infection of the anus due to Neisseria gonorrhoeae |
| 2A02.11 |
paraspinous neuroblastoma |
| 1A70.Y |
Chronic gonococcal prostatitis |
| 2B71 |
Malignant neoplasms of oesophagogastric junction |
| 1A72.0 |
Gonococcal spondylitis |
| 1A61.1 |
primary syphilis of anus |
| 2B72 |
Malignant neoplasms of stomach |
| 2A02.12 |
Other specified malignant neoplasms of optic nerve |
| 2B70 |
Malignant neoplasms of oesophagus |
| 2A42.0 |
Juvenile myelomonocytic leukaemia in complete remission |
| 2A20.0 |
Chronic myelogenous leukaemia, BCR-ABL1-positive |
| 1A61.2 |
primary syphilitic tonsils |
| 1B21.Y |
mycobacteriosis NOS |
| 2A20.1 |
Chronic neutrophilic leukaemia |
| 2A20.2 |
megakaryocytic myeloid metaplasia |
| 2A4Y |
Other specified myelodysplastic and myeloproliferative neoplasms |
| 2A02.1Y |
Olfactory groove meningioma |
| 2D4Y |
Small cell carcinoma of unspecified site |
| 2A4Z |
Myelodysplastic and myeloproliferative neoplasms, unspecified |
| 2B62.0 |
Squamous cell carcinoma of tongue NOS |
| 2B51 |
Osteosarcoma, primary site |
| 2D60.2 |
spleen lymph gland metastasis |
| 1A60.2 |
Late congenital syphilitic chorioretinitis |
| 1B12.4 |
Tuberculosis of the musculoskeletal system |
| 2D81 |
secondary malignant neoplasm of pancreas |
| 1B21.Z |
MOTT - [mycobacteria other than tubercle bacilli] |
| 1A61.0 |
Urethral chancre |
| 1A60.0 |
Early congenital visceral syphilis |
| 2A42.Z |
juvenile myelomonocytic leukaemia without mention of remission |
| 2A42.Y |
Other specified juvenile myelomonocytic leukaemia |
| 2B61.Y |
Other specified malignant neoplasms of base of tongue |
| 1B12.1 |
Tuberculous chorioretinitis |
| 1A62.1 |
Syphilitic pulmonary aneurysm |
| 2B61.0 |
Squamous cell carcinoma of the base of the tongue |
| 2D60.0 |
Supraclavicular lymph gland metastasis |
| 2B62.1 |
Malignant neoplasms of lingual tonsil |
| 1A62.2 |
Symptomatic late syphilis of other sites |
| 1A62.0 |
Neurosyphilis |
| 2B60.1 |
Squamous cell carcinoma of lip |
| 2D60.1 |
Pulmonary lymph gland metastasis |
| 2B61.Z |
malignant neoplasm of anterior two-thirds of tongue, dorsal surface |
| 2D83 |
secondary malignant neoplasm of hepatopancreatic ampulla |
| 2B60.0 |
Basal cell carcinoma of lip |
| 2B62.Y |
Other specified malignant neoplasms of other or unspecified parts of tongue |
| 1A36.1 |
Extraintestinal infections due to Entamoeba |
| 2D80.0 |
hepatic metastases |
| 2D80.1 |
intrahepatic gall ductal metastasis |
| 2B60.Y |
Other specified malignant neoplasms of lip |
| 1B11.Z |
CNS - [central nervous system] TB - [tuberculosis] |
| 1B12.3 |
Tuberculosis of pituitary gland |
| 2E00 |
renal pelvis metastasis |
| 2E02 |
ureteral metastasis |
| 1A36.00 |
Acute nondysenteric amebic enteritis |
| 2E01 |
urinary bladder metastasis |
| 1A36.01 |
Amoeboma of large intestine |
| 1A36.0Y |
nondysenteric amebic diarrhoea |
| 3A00-3A03.Y |
Nutritional or metabolic anaemias |
| 3A10-3A4Z |
Haemolytic anaemias |
| 3A50 |
Thalassaemias |
| 2A33 |
Refractory anaemia with hemochromatosis |
| 1A13 |
Foodborne intoxication due to Bacillus cereus |
| 3B81 |
Acquired disorders of spleen |
| 3B8Z |
splenopathy |
| 3B80 |
Congenital disorders of spleen |
| 2A21.0 |
Systemic mastocytosis |
| 1A1Y |
Foodborne Vibrio parahaemolyticus intoxication |
| 2A21.1 |
Cutaneous mastocytosis |
| 1A60.3 |
Late congenital syphilitic polyneuropathy |
| 2A21.2 |
Mast cell sarcoma |
| 1A70.Z |
Gonococcal genitourinary infection |
| 1A03 |
Intestinal infections due to Escherichia coli |
| 1A04 |
megacolon due to Clostridium difficile |
| 2A34 |
refractory anaemia with sideroblasts with transformation |
| 1A8Z |
Sexually transmissible infections due to chlamydia, unspecified |
| 2B52.1 |
Ewing sarcoma of bone or articular cartilage of pelvis |
| 2A35 |
RAEB 2 - [Refractory anaemia with excess of blasts type 2] |
| 2B52.0 |
Ewing sarcoma of bone or articular cartilage of limbs |
| 2B52.2 |
Ewing sarcoma of bone or articular cartilage of ribs |
| 1A05 |
Colitis due to Yersinia enterocolitica |
| 1A72.3 |
Acute gonococcal pharyngitis |
| 1A72.4 |
Keratitis blennorrhagica |
| 1A11.1 |
Toxin-mediated infectious botulism |
| 2A02.1Z |
Primary malignant neoplasm of vagus nerve |
| 1A11.Z |
Disorders of the neuromuscular junction in botulism |
| 1A11.0 |
Foodborne Clostridium botulinum toxin intoxication |
| 1A61.3 |
Syphilitic alopecia |
| 1B1Z |
Tuberculosis attributable to Mycobacterium tuberculosis |
| 1A61.4 |
Secondary syphilitic lymphadenitis |
| 2A20.3 |
Chronic eosinophilic leukaemia, not elsewhere classified |
| 2B51.0 |
Osseous sarcomas of bone and articular cartilage of mandible |
| 2B51.2 |
Osseous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx |
| 2B62.Z |
primary malignant neoplasm of tongue |
| 2B51.1 |
Osteosarcoma of bone or articular cartilage of limbs |
| 1B12.4Y |
Tuberculosis of other specified part of the musculoskeletal system |
| 1A60.4 |
Congenital syphilitic stigmata |
| 1B12.41 |
Tuberculosis of skeletal muscle |
| 2D60.3 |
Malignant neoplasm metastasis in axillary or arm lymph nodes by other or unspecified epithelial neoplasm |
| 1A61.5 |
latent syphilis, positive serology, early or less than 2 years after infection |
| 2D85 |
ileocecum metastasis |
| 1A60.5 |
Late congenital syphilis, latent |
| 2A50 |
Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement |
| 2A52 |
Myeloid or lymphoid neoplasms with FGFR1 abnormalities |
| 1B12.40 |
Tuberculous rheumatism |
| 2A5Z |
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified |
| 2D60.4 |
Malignant neoplasm metastasis in inguinal or leg lymph nodes by other or unspecified epithelial neoplasm |
| 2B62.10 |
Squamous cell carcinoma of lingual tonsil |
| 2B62.1Z |
primary malignant neoplasm of lingual tonsil |
| 1A62.20 |
Late syphilitic chorioretinitis |
| 1A62.00 |
Asymptomatic neurosyphilis |
| 1A62.0Z |
tertiary central nervous system syphilis |
| 1A62.22 |
Syphilitic gumma |
| 2D60.5 |
Iliac lymph gland metastasis |
| 1A62.01 |
Syphilitic paraplegia |
| 1A62.21 |
Syphilis, stage unspecified, of synovium |
| 2B60.Z |
malignant neoplasm of lip, unspecified |
| 2D8Z |
Malignant neoplasm metastasis in unspecified digestive system organ |
| 2B63.0 |
Squamous cell carcinoma of gum |
| 2D8Y |
submandibular glandular metastasis |
| 2B63.Y |
Malignant neoplasm of alveolar ridge mucosa |
| 2B63.Z |
primary malignant neoplasm of gum |
| 1A36.10 |
amoebic hepatitis |
| 1A36.11 |
Amoebic abscess of lung and liver |
| 1A36.12 |
Amoebic ulcer of skin |
| 3B50-3B51 |
Fibrinolytic defects |
| 3B10-3B4Z |
Coagulation defects |
| 3B60 |
Non-thrombocytopenic purpura |
| 2E04 |
Malignant neoplasm metastasis in soft tissue of abdominal wall |
| 2E03 |
Metastatic fracture of unspecified site |
| 1A36.0Z |
Intestinal infections due to Entamoeba |
| 2E05 |
Malignant neoplasm metastasis in female reproductive system |
| 2B50.0 |
Chondrosarcoma of bone or articular cartilage of limbs |
| 2B50.1 |
Chondromatous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx |
| 2B50.2 |
Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle |
| 1A70.00 |
Gonococcal lymphangitis of penis |
| 1A70.0Z |
gonorrhoeal condyloma |
| 3A00 |
Iron deficiency anaemia |
| 1A70.0Y |
Gonococcal vulvovaginitis |
| 3A02 |
Folate deficiency anaemia |
| 3A01 |
Megaloblastic anaemia due to vitamin B12 deficiency |
| 3A10-3A1Y |
Congenital haemolytic anaemia |
| 3A20-3A2Z |
Acquired haemolytic anaemia |
| 3A4Z |
Haemolytic anaemias, unspecified |
| 2B71.0 |
Adenocarcinoma of oesophagogastric junction |
| 2B71.Z |
primary malignant neoplasm of cardia of stomach |
| 3A50.1 |
Alpha-thalassaemia intellectual disability syndrome linked to chromosome 16 |
| 3A50.0 |
Alpha thalassaemia |
| 3A50.2 |
Beta-thalassemia-X-linked thrombocytopenia syndrome |
| 2B70.1 |
Squamous cell carcinomas of overlapping lesion of oesophagus |
| 2B70.0 |
Adenocarcinoma of oesophagus |
| 1A1Z |
food infection |
| 2B71.Y |
Other specified malignant neoplasm of oesophagogastric junction |
| 2A36 |
5 q- syndrome |
| 2B72.Y |
metastatic gastric carcinoma [primary gastric carcinoma spreading elsewhere] |
| 2B72.0 |
Adenocarcinoma involving overlapping sites of stomach |
| 2B72.1 |
Gastrointestinal APUDomas |
| 2B70.Y |
Metastatic oesophageal carcinoma [primary oesophageal carcinoma spreading elsewhere] |
| 3B81.1 |
acquired absence of spleen |
| 3B81.0 |
SANT - [Sclerosing angiomatoid nodular transformation] |
| 3B81.2 |
Degenerative diseases of the spleen |
| 2A20.4 |
primary polycythaemia |
| 2A21.00 |
Mast cell leukaemia in complete remission |
| 2A21.0Y |
Lymphoadenopathic mastocytosis with eosinophilia |
| 2A21.3 |
Extracutaneous mastocytoma |
| 2A21.0Z |
systemic tissue mast cell disease |
| 2A21.10 |
Maculopapular cutaneous mastocytosis |
| 2A21.1Z |
Cutaneous mastocytosis |
| 3B80.0 |
Splenomegaly in storage diseases |
| 2A21.1Y |
Pseudoxanthomatous nodular cutaneous mastocytosis |
| 1A60.Z |
Late congenital syphilis |
| 1A03.0 |
Colitis in enteropathogenic Escherichia coli infection |
| 2A37 |
Myelodysplastic syndrome, unclassifiable |
| 1A03.1 |
Colitis in enterotoxigenic Escherichia coli infection |
| 1A03.2 |
Colitis in enteroinvasive Escherichia coli infection |
| 2B52.3 |
Malignant peripheral neuroectodermal tumour of cervix uteri |
| 2B52.Y |
Extraosseous Ewing sarcoma |
| 2B52.Z |
Ewing's sarcoma/peripheral neuroectodermal tumour [PNET] |
| 2A38 |
Refractory cytopenia of childhood |
| 1A72.Y |
Gonococcal skin lesions |
| 2E65.1 |
Lobular carcinoma in situ of breast, pleomorphic subtype |
| 1A61.Y |
Other specified early syphilis |
| 2E65.0 |
Lobular carcinoma in situ of right breast |
| 2E65.2 |
Intraductal carcinoma in situ of left breast |
| 2E66.Y |
Squamous cell carcinoma in situ with questionable stromal invasion of unspecified site |
| 2E66.Z |
Carcinoma in situ of other parts of cervix |
| 2E67 |
Carcinoma in situ of other or unspecified genital organs |
| 2E66.2 |
cervical intraepithelial neoplasia grade II |
| 2A20.5 |
Non mast cell myeloproliferative neoplasm, unclassifiable |
| 1A61.Z |
general syphilis |
| 1A73 |
Disseminated infection due to Neisseria gonorrhoeae |
| 2B51.Y |
Li-Fraumeni syndrome |
| 2B51.Z |
osteogenic sarcoma |
| 1B12.4Z |
Tuberculosis of the musculoskeletal system |
| 2D60.Y |
Other specified malignant neoplasm metastasis in lymph node of a single region |
| 2A60.20 |
Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor |
| 2A60.2Z |
therapy-related myelodysplastic syndromes |
| 2A60.2Y |
Other specified therapy-related myeloid neoplasms |
| 2A60.31 |
Acute myeloblastic leukaemia without maturation |
| 2A60.30 |
Minimally differentiated acute myeloblastic leukaemia |
| 2A60.40 |
Transient abnormal myelopoiesis |
| 2A60.32 |
Acute myeloblastic leukaemia with maturation |
| 2A60.41 |
Myeloid leukaemia associated with Down syndrome |
| 2A60.4Y |
Other specified myeloid proliferation associated with Down syndrome |
| 2D60.Z |
Malignant neoplasm metastasis in lymph node of a single region |
| 1B21.20 |
Buruli ulcer |
| 1B21.2Z |
Atypical mycobacterial infection of the skin |
| 1B21.2Y |
Cutaneous Mycobacterium kansasii infection |
| 2B64.0 |
Squamous cell carcinoma of floor of mouth |
| 2B64.Z |
primary malignant neoplasm of floor of mouth |
| 2B64.Y |
Other specified malignant neoplasm of floor of mouth |
| 1A62.2Z |
Symptomatic late syphilis of other sites |
| 1A62.2Y |
Late syphilitic peritonitis |
| 1A62.Y |
Syphilis positive serology, late or 2 years or more after infection |
| 2B65 |
Malignant neoplasms of palate |
| 2B66 |
Malignant neoplasms of other or unspecified parts of mouth |
| 1A36.1Y |
Amoebic vulvovaginitis |
| 3B50 |
Inherited fibrinolytic defects |
| 3B51 |
Fibrinolytic disorder due to administration of other drugs |
| 3B10-3B1Z |
Congenital or constitutional haemorrhagic condition |
| 3B20-3B2Y |
Haemorrhagic diseases due to acquired coagulation factor defects |
| 3B4Z |
coagulopathy NOS |
| 2E06 |
Malignant neoplasm metastasis in penis |
| 2E05.Z |
Malignant neoplasm metastasis in female reproductive system |
| 2E05.0 |
Secondary mucinous adenocarcinoma of ovary |
| 2E05.Y |
vaginovesical septum metastasis |
| 2E07 |
suprarenal gland metastasis |
| 1B12.7 |
Tuberculous ascites |
| 2B50.Z |
chondrosarcoma NOS |
| 2B50.Y |
Chondromatous sarcomas of bone and articular cartilage of vertebral column |
| 3A00.0 |
Acquired iron deficiency anaemia due to blood loss |
| 3A00.1 |
Iron deficiency anaemia due to malnutrition |
| 3A00.2 |
Acquired iron deficiency anaemia due to coeliac disease |
| 1A06 |
Colitis due to Campylobacter |
| 3A02.0 |
Hereditary folate deficiency anaemia |
| 3A02.2 |
Acquired megaloblastic anaemia associated with psoriasis |
| 3A02.1 |
megaloblastic anaemia due to poor nutrition |
| 3A01.1 |
Nutritional vitamin B12 deficiency due to maternal vitamin B12 deficiency in breast-fed infants |
| 3A01.0 |
Anaemia due to selective hereditary vitamin B12 malabsorption with proteinuria |
| 3A01.2 |
vegan anaemia NOS |
| 3A1Y |
congenital heinz body haemolytic anaemia |
| 3A10 |
Hereditary haemolytic anaemia |
| 3A20 |
Acquired haemolytic anaemia, immune |
| 3A21 |
Acquired haemolytic anaemia, non-immune |
| 3A2Z |
haemoglobinaemia |
| 3A50.3 |
Haemoglobin Lepore |
| 2B70.Z |
Metastatic oesophageal cancer [primary oesophageal cancer spreading elsewhere] |
| 2B70.00 |
Barrett adenocarcinoma |
| 2B70.0Z |
oesophageal adenocarcinoma |
| 2B70.0Y |
Adenocarcinoma involving overlapping sites of oesophagus |
| 2B80-2C0Z |
Malignant neoplasms of intestine |
| 2A3Y |
Refractory anaemia with excess blasts in childhood |
| 2B72.Z |
cancer of pylorus of stomach |
| 3B81.5 |
Splenic cyst or pseudocyst |
| 3B81.3 |
Nontraumatic laceration or rupture of spleen |
| 3B81.4 |
Splenosis |
| 2A20.Y |
Other specified non mast cell myeloproliferative neoplasms |
| 2A21.Y |
Other specified mastocytosis |
| 2A21.Z |
malignant mastocytosis |
| 1A03.3 |
Colitis in enterohaemorrhagic Escherichia coli infection |
| 2A3Z |
preleukaemic syndrome |
| 1A03.Y |
EAEC - [Enteroaggregative Escherichia coli] infection |
| 1A03.Z |
Escherichia coli enteritis, not otherwise specified |
| 2B53 |
Fibroblastic or myofibroblastic tumour, primary site |
| 2E65.3 |
Ductal carcinoma in situ of breast, comedo subtype |
| 2E65.4 |
lobular with intraductal carcinoma in situ |
| 2A20.02 |
Chronic myelogenous leukaemia, t(9:22)(q34; q11) |
| 2A20.01 |
Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive |
| 2A20.00 |
Chronic myelogenous leukaemia with blast crisis |
| 2A20.Z |
Non mast cell myeloproliferative neoplasms |
| 2E68 |
carcinoma in situ of urinary bladder |
| 2B54 |
Undifferentiated pleomorphic sarcoma, primary site |
| 1B12.Y |
Tuberculosis of adenoids, with bacteriological and histological confirmation |
| 2A60.5 |
agranular CD4+ NK leukaemia |
| 2A60.33 |
Acute myelomonocytic leukaemia in complete remission |
| 2A60.4Z |
Myeloid proliferation associated with Down syndrome |
| 2A60.34 |
AML M5b |
| 2A60.35 |
Acute erythroid leukaemia in complete remission |
| 2E2Z |
Secondary carcinoma of unspecified site |
| 2B67 |
Malignant neoplasms of parotid gland |
| 1A62.Z |
late tertiary syphilis |
| 1A07 |
Typhoid fever |
| 3B10 |
Hereditary factor VIII deficiency |
| 3B50.0 |
Congenital alpha2 antiplasmin deficiency |
| 3B11 |
Hereditary factor IX deficiency |
| 3B50.Y |
Excessive release of tPA - [tissue-type plasminogen activator] |
| 3B50.1 |
Congenital PAI-1 - [plasminogen activator inhibitor type 1] deficiency |
| 3B12 |
Von Willebrand disease type 3 |
| 2E08 |
Malignant metastasis neoplasm involving skin of abdominal wall |
| 3A50.02 |
Alpha thalassaemia intermedia |
| 3A50.00 |
Heterozygous non-deletional alpha thalassaemia (αTα/αα and ααT/αα included) |
| 3A50.01 |
Haemoglobin Constant Spring |
| 2E09 |
Malignant neoplasm metastasis in peripheral nervous system |
| 2E0Y |
orbit metastasis |
| 2B55 |
Rhabdomyosarcoma, primary site |
| 3A00.3 |
Acquired iron deficiency anaemia due to increased requirement in pregnancy |
| 3A00.Y |
microcytic anaemia NOS |
| 3A02.3 |
Megaloblastic anaemia due to decreased intestinal absorption of folate |
| 3A02.4 |
megaloblastic anaemia due to drug-induced folate deficiency |
| 1A08 |
Colitis due to paratyphoid fever C |
| 3A01.3 |
Vitamin B12 deficiency anaemia due to intrinsic factor deficiency |
| 3A02.Y |
Tropical macrocytic anaemia |
| 3A20.2 |
Autoimmune haemolytic anaemia, mixed type, cold and warm |
| 3A01.4 |
Acquired megaloblastic anaemia due to vitamin B12 deficiency secondary to intestinal disease |
| 3A20.0 |
acute Lederer haemolytic anaemia |
| 3A10.1 |
Haemolytic anaemia due to adenosine deaminase excess |
| 3A20.1 |
cold hemagglutinin disease |
| 3A10.0 |
Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies |
| 3A21.2 |
Glomerular disorders in haemolytic uraemic syndrome |
| 3A10.2 |
Hereditary pyropoikilocytosis |
| 3A21.1 |
Neoplastic microangiopathic haemolytic anaemia |
| 3A21.0 |
nocturnal paroxysmal haemoglobinaemia |
| 3A50.4 |
Hereditary persistence of fetal haemoglobin, non-deletional |
| 2E65.5 |
Paget disease of nipple |
| 2E67.0 |
endometrial carcinoma in situ |
| 2E67.1 |
vulvar carcinoma in situ |
| 2E67.2 |
Carcinoma in situ of vagina |
| 2C10 |
Malignant neoplasm of pancreas |
| 3B81.51 |
Epithelial cyst of spleen |
| 3B81.5Y |
Other specified splenic cyst |
| 3B81.50 |
Pseudocyst of spleen |
| 3B81.7 |
Infection of spleen |
| 3B81.6 |
Subcapsular splenic haemorrhage |
| 2B65.0 |
Salivary gland-type carcinoma of palate |
| 2B65.1 |
Squamous cell carcinoma of palate |
| 2B65.Y |
Carcinoma of palate |
| 2A61 |
Mixed phenotype acute leukaemias, T and myeloid, not elsewhere classified |
| 1A09 |
Infections due to other Salmonella |
| 2B66.0 |
Squamous cell carcinoma of other or unspecified parts of mouth |
| 2B53.0 |
fibromyxosarcoma of unspecified site |
| 2B53.1 |
Fibroblastic or myofibroblastic tumour of skin |
| 2B53.Y |
pigmented dermatofibrosarcoma |
| 2B66.Y |
Other specified malignant neoplasms of other or unspecified parts of mouth |
| 2B66.Z |
primary malignant neoplasm of oral cavity |
| 3B21 |
Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors |
| 3B22 |
Acquired factor XIII deficiency |
| 3B20 |
acquired fibrinogenopenia |
| 2E65.Y |
Solid papillary carcinoma in situ of breast |
| 2E65.Z |
Breast cancer in situ |
| 2A20.03 |
Naegeli-type monocytic leukaemia |
| 2A20.0Y |
chronic myeloid leukaemia, BCR-ABL-positive in complete remission |
| 2A20.0Z |
chronic myeloid leukaemia, BCR-ABL-positive without mention of remission |
| 2E69 |
Carcinoma in situ of other or unspecified urinary organs |
| 2B54.0 |
malignant fibrous histiocytoma of unspecified site |
| 2B54.Y |
Undifferentiated pleomorphic sarcoma, other specified primary site |
| 2B54.1 |
Undifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum |
| 1A81.Y |
Chlamydial colitis |
| 1A81.1 |
Male chlamydial pelviperitonitis |
| 2A60.Y |
Other specified acute myeloid leukaemias and related precursor neoplasms |
| 1A81.0 |
Chlamydial cervicitis |
| 2A60.Z |
Acute myeloid leukaemias and related precursor neoplasms |
| 2A60.36 |
Acute megakaryoblastic leukaemia in complete remission |
| 2A60.37 |
Acute basophilic leukaemia |
| 1B41.1 |
Acute rheumatic endocarditis |
| 1B41.0 |
acute rheumatic bacterial pericardium inflammation |
| 2A60.38 |
Acute myelofibrosis in complete remission |
| 1B41.2 |
acute rheumatic toxic myocarditis |
| 1A07.Z |
enteric fever NOS |
| 1A07.0 |
typhoperitonitis |
| 1A07.Y |
Typhoid colitis |
| 3A00.01 |
chronic haemorrhagic anaemia |
| 3A00.0Z |
haemorrhagic anaemia |
| 3B10.Y |
Other specified hereditary factor VIII deficiency |
| 3B10.1 |
Hereditary factor VIII deficiency with anti-factor VIII inhibitor |
| 3B10.0 |
Symptomatic form of haemophilia A in female carriers |
| 3B50.Z |
Inherited fibrinolytic defects |
| 3B11.Y |
Other specified hereditary factor IX deficiency |
| 3B11.Z |
intravascular clotting defect |
| 3B11.0 |
Symptomatic form of haemophilia B in female carriers |
| 3A50.03 |
Haemoglobin Bart hydrops fetalis |
| 3A50.0Y |
Alpha thalassaemia myelodysplastic syndrome |
| 3A50.0Z |
alpha thalassaemia syndrome |
| 2B80 |
Malignant neoplasms of small intestine |
| 2B81 |
Malignant neoplasms of appendix |
| 2B90-2B9Y |
Malignant neoplasms of large intestine |
| 1A94 |
Anogenital herpes simplex infection |
| 2B55.2 |
Rhabdomyosarcoma of male genital organs |
| 2B55.0 |
Rhabdomyosarcoma of the oral cavity or pharynx |
| 2B55.1 |
Alveolar rhabdomyosarcoma |
| 3A00.Z |
Fe - [iron] deficiency anemia NOS |
| 3A02.Z |
Folic acid deficiency anaemia NOS |
| 3A01.5 |
Megaloblastic anaemia due to drug-induced vitamin B12 deficiency |
| 3A20.3 |
Donath-Landsteiner syndrome |
| 3A10.3 |
Familial pseudohyperkalaemia, Cardiff type |
| 1A0Y |
Neonatal bacterial intestinal infection |
| 3A10.0Z |
anaemia due to other disorders of glutathione metabolism |
| 3A10.00 |
anaemia due to haemolytic nonspherocytic (hereditary), type 1 |
| 3A10.0Y |
anaemia due to 6-phosphogluconate dehydrogenase deficiency |
| 3A21.Y |
Atypical haemolytic uraemic syndrome with anti-factor H antibodies |
| 3A50.Y |
Thalassaemia minor |
| 2E67.3 |
Carcinoma in situ of other or unspecified female genital organs |
| 2E67.2Z |
Squamous cell carcinoma in situ of vagina |
| 2E67.22 |
severe vaginal dysplasia, NEC |
| 2E67.2Y |
Other specified carcinoma in situ of vagina |
| 3B81.5Z |
Splenic cyst or pseudocyst |
| 2C11 |
Malignant neoplasms of other or ill-defined digestive organs |
| 3B81.71 |
splenic abscess |
| 3B81.7Y |
Other specified infection of spleen |
| 3B81.70 |
septic spleen |
| 2B67.1 |
Squamous cell carcinoma of parotid gland |
| 2B67.0 |
Acinar cell carcinoma of parotid gland |
| 2B67.Y |
Other specified malignant neoplasms of parotid gland |
| 2B65.Z |
malignant neoplasm of upper or lower labial sulcus |
| 1A09.Y |
Pneumonia due to salmonella infection |
| 1A09.Z |
Sepsis due to Salmonella infection with septic shock |
| 2A70-2A7Z |
Precursor lymphoid neoplasms |
| 1A09.0 |
salmonellosis |
| 2B53.Z |
Fibroblastic or myofibroblastic tumour, primary site |
| 2B68 |
Malignant neoplasms of submandibular or sublingual glands |
| 3A01.Y |
Addison anaemia |
| 3B2Y |
Acquired stable factor deficiency |
| 2E6A |
Carcinoma in situ of the eye or ocular adnexa |
| 2A80-2A8Z |
Mature B-cell neoplasms |
| 2B54.Z |
Undifferentiated pleomorphic sarcoma, primary site |
| 2E6B |
Carcinoma in situ of thyroglossal duct |
| 1A81.Z |
other sexually transmitted chlamydial diseases |
| 1B41.10 |
Rheumatic aortitis |
| 2A60.39 |
Myeloid sarcoma in complete remission |
| 1B41.1Z |
Acute rheumatic valvulitis |
| 2A60.3Y |
Acute myeloid leukaemia, NOS by criteria of other types in complete remission |
| 1B41.Y |
Acute rheumatic coronary arteritis |
| 1B41.1Y |
Active or acute tricuspid endocarditis |
| 1B41.Z |
acute RHD - [rheumatic heart disease] |
| 1A0Z |
Phlegmonous colitis |
| 3B10.Z |
Deficiency factor VIII with functional defect |
| 3B61 |
Thrombophilia |
| 3A01.3Z |
Acquired megaloblastic anaemias due to vitamin B12 deficiency secondary to intrinsic factor deficiency |
| 3A01.30 |
Pernicious anaemia associated with other autoimmune disorders |
| 3A01.3Y |
Vitamin B12 deficiency anaemia associated with total gastrectomy |
| 3A21.Z |
acquired haemolytic anaemia, non-immune NOS |
| 3A50.Z |
thalassemia variants |
| 2E67.11 |
Extramammary Paget disease of vulva |
| 2E67.12 |
DVIN [Differentiated vulvar intraepithelial neoplasia] |
| 2E67.13 |
High grade squamous intraepithelial lesion of vulva NOS |
| 2C10.0 |
Intraductal papillary-mucinous carcinoma of pancreas |
| 2C10.Y |
Pancreatoblastoma |
| 2C10.1 |
Increased secretion from endocrine pancreas of pancreatic polypeptide |
| 1A94.1 |
Herpetic proctitis |
| 1A94.0 |
Herpes simplex infection of male genital tract NOS |
| 1A94.Z |
anogenital HSV - [herpes simplex virus] infection |
| 3B81.8 |
Torsion of spleen |
| 2B55.Y |
Myosarcoma of overlapping lesion of corpus uteri |
| 2B55.Z |
Rhabdomyosarcoma, primary site |
| 3A03 |
Other nutritional or metabolic anaemias |
| 3B21.0 |
Haemorrhage due to thrombin inhibitor other than heparin |
| 3B21.1 |
Haemorrhage due to factor Xa inhibitor |
| 3B21.Y |
Haemorrhagic disorder due to increase in anti-XIa |
| 3A01.Z |
Megaloblastic anaemia due to vitamin B12 deficiency |
| 3A20.4 |
Lymphocyte passenger syndrome, following organ transplantation |
| 3A10.Y |
Atypical haemolytic uraemic syndrome with thrombomodulin anomaly |
| 2E67.4 |
PIN - [penile intraepithelial neoplasia] |
| 2E67.5 |
carcinoma in situ prostate |
| 3B81.9 |
fibrotic spleen |
| 3B81.7Z |
interstitial splenitis |
| 1A95 |
Anogenital warts |
| 2B67.Z |
primary malignant neoplasm of parotid gland |
| 2A60.3Z |
AML - [Acute myeloid leukaemia] |
| 2B69 |
Malignant neoplasms of tonsil |
| 2A70 |
Precursor B-lymphoblastic neoplasms |
| 2A7Z |
Precursor lymphoid neoplasms, unspecified |
